Feder L S, Laskin D L
Department of Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey 08855-0789.
J Leukoc Biol. 1994 Apr;55(4):507-13.
Treatment of rats with bacterially derived lipopolysaccharide (LPS), a condition that mimics acute endotoxemia, results in a significant increase in the number of endothelial cells and macrophages in the liver. This is correlated with the release of proinflammatory and cytotoxic mediators that induce liver damage. In the present studies, we analyzed the effects of various inflammatory mediators released during the pathogenesis of hepatic injury on proliferation of liver nonparenchymal cells. To induce acute endotoxemia female Sprague-Dawley rats were injected intravenously with 5 mg/kg LPS. Endothelial cells and macrophages were isolated 48 h later by combined collagenase and pronase perfusion of the liver followed by centrifugal elutriation. Interleukin-1 alpha (IL-1 alpha), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha) had no effect on proliferation of either endothelial cells or macrophages. In contrast, whereas interleukin-1 beta (IL-1 beta) inhibited the proliferation of endothelial cells from untreated rats, this cytokine stimulated the growth of cells from endotoxemic rats. The colony-stimulating factors, granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF), also markedly enhanced the proliferation of endothelial cells, as well as macrophages from endotoxemic rats. Macrophages from endotoxemic rats were more sensitive to the colony-stimulating factors than cells from untreated rats. In contrast, the inflammatory mediators LPS and interferon-gamma (IFN-gamma) inhibited endothelial cell and macrophage growth, an effect that was partially blocked in endothelial cells by the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA). This suggests that growth inhibition in these cells is mediated, in part, by nitric oxide. Interestingly, in both endothelial cells and macrophages from endotoxemic rats, GM-CSF, M-CSF, and IL-1 beta synergized with LPS and IFN-gamma to induce nitric oxide production. This was correlated with a further inhibition of proliferation that was partially reversed by L-NMMA in endothelial cells but not macrophages. Taken together these data demonstrate that endothelial cell and macrophage proliferation in the liver is controlled by a variety of mediators released during endotoxemia; however, the mechanisms regulating growth in the two cell types are distinct.
用细菌衍生的脂多糖(LPS)处理大鼠,这种情况模拟急性内毒素血症,会导致肝脏中内皮细胞和巨噬细胞数量显著增加。这与诱导肝损伤的促炎和细胞毒性介质的释放相关。在本研究中,我们分析了肝损伤发病过程中释放的各种炎症介质对肝非实质细胞增殖的影响。为诱导急性内毒素血症,给雌性Sprague-Dawley大鼠静脉注射5mg/kg LPS。48小时后,通过胶原酶和链霉蛋白酶联合灌注肝脏,随后进行离心淘析,分离出内皮细胞和巨噬细胞。白细胞介素-1α(IL-1α)、白细胞介素-6(IL-6)和肿瘤坏死因子α(TNF-α)对内皮细胞或巨噬细胞的增殖均无影响。相反,白细胞介素-1β(IL-1β)抑制未处理大鼠的内皮细胞增殖,但这种细胞因子刺激内毒素血症大鼠的细胞生长。集落刺激因子,即粒细胞-巨噬细胞集落刺激因子(GM-CSF)和巨噬细胞集落刺激因子(M-CSF),也显著增强内毒素血症大鼠的内皮细胞以及巨噬细胞的增殖。内毒素血症大鼠的巨噬细胞比未处理大鼠的细胞对集落刺激因子更敏感。相反,炎症介质LPS和干扰素-γ(IFN-γ)抑制内皮细胞和巨噬细胞生长,一氧化氮合酶抑制剂NG-单甲基-L-精氨酸(L-NMMA)可部分阻断内皮细胞中的这种作用。这表明这些细胞的生长抑制部分是由一氧化氮介导的。有趣的是,在内毒素血症大鼠的内皮细胞和巨噬细胞中,GM-CSF、M-CSF和IL-1β与LPS和IFN-γ协同诱导一氧化氮产生。这与进一步的增殖抑制相关,L-NMMA可部分逆转内皮细胞中的这种抑制,但对巨噬细胞无效。综上所述,这些数据表明肝脏中内皮细胞和巨噬细胞的增殖受内毒素血症期间释放的多种介质控制;然而,调节这两种细胞类型生长的机制是不同的。